Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease (AD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02947893
Recruitment Status : Active, not recruiting
First Posted : October 28, 2016
Last Update Posted : March 13, 2019
Sponsor:
Information provided by (Responsible Party):
R. Scott Turner, Georgetown University